重症心不全に対する植込型補助人工心臓治療
Contents
1. MJR EBB H BRAK Ea Jt Hid Jt E mAs CE A E E E E S JE HS 3 JB JB mE2. DIAL II Ia IIb DIAL LAW A
3. HOWL ES om Wut SEHE D
4. OBIT fe WE c 8 TE Bis JOE E EEIZBIS SOA 2013 BTD BIT BTR DT DT lt 3 5 2 LVAD LVAD
5. 3 3 3 3 1 NA 4E 1
6. pui TE Bie OBM E ACET SOT 2013 3 3 6 LVAD
7. LVAD F de air LVAD LVAD LVAD LVAD TEE
8. JE 5 8 I 68 Edir 7 gt JRA 1 4 3 lt 5 AA 3 1 2 TE BE DET E EISE SOL 2073 2011 2012 a
9. TAP VAD 3 1 4 VAD VAD VAD VAD LVAD 197 254 Heyde angiodysplasia 2 von Willebrand vWF jk 4p 250 shear stress vWF
10. inflow cuff 3 5 3 5 1 LVAD LVAD BTT BTR LVAD DT LT BTD LVAD BTT BTR BTD DT LVAD
11. B i 100 4 5 6 f FESS 8 5 3 1 90
12. 9 590 Ca e 2 4 2 __ TEE LVAD de air TEE 151 152 a PFO LVAD
13. ZH E 99 FFP CODES IDE TX Wal EXSY K BA 2 5 4 VAD
14. gi Fontan LVAD 2005 LVAD 779 OB Clark 89 Glenn LVAD Fontan Glenn LVAD
15. CRP C X AVE 217 VAD VAD
16. Profile 1 SOWA LVAD v VAD LVAD PCPS Profile 1 VAD LVAD VAD 2 3 LVAD
17. RVAD 2520 2 5 15 J MACS VAD 6 144 LVAD BE 39220 n 20
18. WER aI OPE E ARBRIT SAT 2013 2011 2012 AE b RVAD 199
19. 5 20uglkg min 0 05 0 5 uglkg min PDE III NO 20 40 ppm 2 15 U hr 8 d LVAD 9 FFP
20. S90 VAD VAD 65 3 80 2 99 VAD
21. IABP VAD 24 2012 4 LVAD JOTN K604 2 19 LVAD LVAD 1 D 2005 Novacor K604 2 2 LVAD
22. T EVAHEART DuraHeart ILS intermittent low speed Jarvik 2000 HAH LVAD
23. 2011 3 79 2012 10 Richardson P McKenna W Bristow M et al Report of the 1995 World Health Organization International Society and Federation of Cardiology Task Force on the Definition and Classification of cardiomyopathies Circulation 1996 93 841 842 Silver MM Silver MD Cardiomyopathies In Silver MD editor Cardiovascular Pathology 2nd ed Churchill Livingstone 1991 743 809 Miura K Nakagawa H Morikawa Y et al Epidemiology of idiopathic cardiomyopathy in Japan results from a nationwide survey Heart 2002 87 126 130 Miura K Matsumori A Nasermoaddeli A et al Prognosis and prognostic factors in patients with idiopathic dilated cardiomyopathy in Japan Circ J 2008 72 343 348 Abraham WT Fisher WG Smith AL et al Cardiac resynchronization in chronic heart failure N Engl J Med 2002 346 1845 1853 Moss AJ Hall WJ Cannom DS et al Cardiac resynchronization therapy for the prevention of heart failure events N Engl J Med 2009 361 1329 1338 Cleland JG Daubert JC Erdmann E et al Longer term effects of cardiac resynchronization therapy on mortality in heart failure the CArdiac REsynchronization Heart Failure CARE HF trial exte
24. 109 LVAD g LVAD
25. WES 11922279 WER ae IG OREM E ARBRIT SAL 2013 2011 2012 116 3 2 21 _ LVAD
26. LVAD LVAD LVAD WER ae IG OREM E ARBRIT SAT 2013 gt 2011 2012
27. 10 35 55 30 50 102 2 1 10 VAD VAD QOL UE
28. HAH LVAD X CTR CT TEE 259 VAD VAD VAD ACE ARB Ca
29. EVAHEART 1500rpm APTT 1 5 2 0 PT INR 2 5 3 5 WERE OBZ EVERITT 2013 2 3 2 DuraHeart DuraHeart LVAD Wit S M L 3
30. 3 3 7 a QOL 3P X 2 b 79 30 40
31. VAD bridge to decision VAD C LVAD llb B 1 CRT LVAD BIT 72A VAIL B 2 Na ME SWE BRE lla B 3 CRT
32. VAD LL TEER ASE c VAD 2 5 7 _ WER ae OREM E ARBRIT SAL 2013 2011 2012 VAD
33. E VAD 2 VAD GRAVE X BF X PDE M NO RVAD
34. 6 8 20 FICHE BIDS L 194248 pump endocarditis LVAD 2 2 9 30 3 1 3 1 22 LVAD 59 d
35. COD BEE aa mz A ER E TIVE CSL WB MSD WB ORA WE ARLE ADE zo 2 se FIVE CSL
36. CT FFP LVAD 0
37. 1 3 1 8METs 3 30 io 32 c
38. St LE WER ae OREM E ARBRIT SOT FAL 2013 2011 2012 HeartMate II BTT 281 8 THE 4 139 c d SHREE MS MS e MR MR VAD MR HeartMate II BTT
39. V LVAD LVAD LVAD J MACS brdge to transplantation possible bridge to transplantation possible bridge to transplantation destination therapy ADHF bridge to recovery ADHF OBEREZ7 l KERET rescuetherapy 1 1 2 bridge to transplantation BTT LVAD
40. Vo PCPS LVAD PCPS e fet LC LVAD VAD
41. VAD 19 9 Hee Pe CT VAD 192 194 2 5 3 VAD
42. 2 29 265 255 256 II AR
43. 1 1 2 3 4 3 TE Bt os AO REBE E SELBE AUNT 2013 2011 2012 65
44. ST TEE Trendelenburg 199 2 4 3 a
45. VAD 10 BERL 8 EE TE peripartum cardiomyopathy VAD BTR BTR 39 VAD LVAD 1 2 VAD 124 VAD
46. PDE IABP 65 65 stage D NYHA 75 AN OBHE QOL QOL COPD 30 2
47. CRT 449 4850 c VAD BE 3 10 7A 17 3 A EXKI 4 1 5 4j E 86 9 Fabry p
48. 2010 http wwwj circ or jp guideline pdf7 JCS2010_matsuzaki_hpdf 2012 10 Tang AS Wells GA Talajic M et al Cardiac resynchronization therapy for mild to moderate heart failure N Engl J Med 2010 363 2385 2395 Yoshioka D Sakaguchi T Saito S et al Initial experience of conversion of Toyobo paracorporeal left ventricular assist device to DuraHeart left ventricular assist device Circ J 2012 76 372 376 Worku B Pak SW van Patten D et al The CentriMag ventricular assist device in acute heart failure refractory to medical management J Heart Lung Transplant 2012 31 611 617 Samuels LE Thomas MP Holmes EC et al Insufficiency of the native aortic valve and left ventricular assist system inflow valve after support with an implantable left ventricular assist system signs symptoms and concerns J Thorac Cardiovasc Surg 2001 122 380 381 Hatano M Kinugawa K Shiga T et al Less frequent opening of the aortic valve and a continuous flow pump are risk factors for postoperative onset of aortic insufficiency in patients with a left ventricular assist device Circ J 2011 75 1147 1155 Goda A Takayama H Pak SW et al Aortic valve procedures at the time of ventricular assist device placement Ann Thorac Surg 2011 91 750 754 Feldman CM Silver MA Sobieski MA et al Man
49. Na 109 2 1 4 AST ALT LVAD 2 LVAD LVAD 2 0 5 0 mg dL LVAD LVAD 2 1 5 Na
50. III VAD VAD PREA AMPLAZER266267 78 3 1 6 _ VAD ICD VAD
51. 19 O Bka Swan Ganz 10048 VAD 2 4 4 RVAD
52. 185 180 IABP 7 281 HeartMate II 30 26 9 3 Va A 188 g HK HAMIL LTH 9 VAD
53. 53 59 E Th Th LT gt IH TE Bi ODER E ACET SOA 2013 d 39 VAD 5 8 EF VAD e
54. 235 236 237 238 239 240 24 par 242 244 245 246 247 248 249 250 251 252 253 254 255 256 257 258 259 260 Kartha V Gomez W Wu B et al Laparoscopic cholecystectomy in a patient with an implantable left ventricular assist device Br J Anaesth 2008 100 652 655 De Silva A Smith T Stroud M Attitudes to NICE guidance on refeeding syndrome BMJ 2008 337 a680 Mehanna HM Moledina J Travis J Refeeding syndrome what it is and how to prevent and treat it BMJ 2008 336 1495 1498 2012 325 335 Teuteberg J Lockard K Chapter 14 Predischarge and outpatient management In Kormos RL Miller LW editors Mechanical circulatory support a companion to Braunwald s heart disease Elsevier Saunders 2012 183 193 Moazami N Smedira NG McCarthy PM et al Safety and efficacy of intraarterial thrombolysis for perioperative stroke after cardiac operation Ann Thorac Surg 2001 72 1933 1937 discussion 1937 1939 Masotti L Di Napoli M Godoy DA et al The practical management of intracerebral hemorrhage associated with oral anticoagulant therapy Int J Stroke 2011
55. LS Profile 3 INTERMACS Profile 4 VAD Profile 4 6 Status 2 LVAD INTERMACS modifierA 1 2 ICD VAD 85 82 1 2 b 2013 65 io LVAD 65 LVAD 2 3 166 167 5 BMI
56. 2 3 1 EVAHEART EVAHEART LVAD D 118 800 rpm 1500 rpm
57. 2011 2012 LVEE30 LVEDD 65 mm RY TIE Fic LVEF PCWP 3 LVAD LVAD HeartMatell destination therapy trial 1108 LVAD 1 8 3 LVAD t LVAD reverse remodeling LVAD 3 LVAD LVAD AR 3 AR reverse remodeling 3 ORRO inflow cuff
58. VAD VAD 1 2 2 _ a 488 Sc 79 b LVAD 2006 NHLBI 5 3 LVAD PediPump7 infant Jarvik PediaFlow VAD LVAD 7 LVAD 79
59. WER ae OBI E EBIB AT 2013 VAD VAD E 3 2 3 VAD LVAD 90
60. BTT LVAD E34 LGA LT 2005 2006 2010 LVAD m TE Bi JOE E ACTER 2013 Il Sin EU NE NG MN ERE DRE ES 158 1 RR RR NR Aad qi iQ V Rcs 1 58 2 163 p IB 00o 174 et ERU esa bbe bua aioe SR RR UHR 181 rm 183 NS E A a A A A E 184 2010 11 16 2
61. S 14mm 119 VAD BTB VAD ROO VAD CE 14 mm 87 24 72 APTT 0 70 PT INR H2 5 3 0 3
62. 5 m EBD SE ACT 3 2013
63. 69 TE Bi JOE E ACTER FFI 2013 RVAD LVAD 2 8 6 3 127 133 171 172 RVAD Profile1 1 Profile2 93 Profile 3 7 RVAD 3 RVAD 79 7 Jarvik LVAD Jarvik RVAD HeartWare LVAD HeartWare RVAD DuraHeart LVAD Jarvik RVAD VAD 2 5 l ICU E
64. EBM FEA LVAD EVAHEART DuraHeart HeartMate II Jarvik 2000 4 36 LVAD LVAD LVAD Bot
65. 9 b 4 E A PERLE ZS CREE ULE Fabry ii ADNAN 4m AO 10 14 0 A 3 6 99 5 6 3 75 7 3 VAD
66. 8000 12000 rpm 64 8 intermittent low speed 13129 29 APTT f 40 45 L PT INR 2 0 3 0 2 2 3 5 HeartWare Ventricular Assist Device HVAD 128 29 R
67. 9 9198 99 100 100 LVAD LVAD 2
68. REPR E 2 4 l VAD 2 4 1 a A TE Bip JOE E ACTER FIY 2073 39 2 8 BIS bispectral index 4 4 b
69. 289 32 7 8 3P 3P H
70. J MACS 1 Tr kinking 15648118 A 2 5 2 ME LVAD
71. 150 MS LVAD 7 5 mm 9 TEE 9 LVAD TEE LVAD I LVAD 2
72. 186 204 210 1 2 21 RVAD 215 217 2 5 14 J MACS 14 GOT AST GPT ALT 2 3 LVAD 25 219 amp lt
73. 2 3 4 Jarvik 2000 Jarvik 2000 2 5 cm 90 g 1 2 m 2 3 24 20 mm
74. iia v TE Bie JOE E ACET SOT FIY 2013 OEY BTT 1 1 3 bridge to candidacy BTC LVAD LVAD 22 L
75. 20 VAD VAD FILE STIEN p 052 LVAD 233 239 2 5 19
76. C AR AR LVAD LVAD AR 9 AR LVAD 91 9 ZRF TR MR TR 9 TR MR LVAD
77. 3 D WER ae IG OREM E ARBRIT SAL FAL 2013 2011 2012 refeeding 236 238 VAD re 3
78. VAD IMACS Japanese registry for Mechanically Assisted Circulatory Support J MACS zi TE Bi ORE E ARIAT SOA BAT 2013 LVAD 2 2 3 2010 1 1
79. 242 PT INR 239 TE Bis JOE E ACET 3T 2013 312 a 9 EK PIA 724 VAC CECH B
80. 191 192 VAD LVAD VAD if 7 CNH ATC 9 2 5 18 VAD 22227 28229 LVAD
81. 7 b D El volume of distribution 99 SET 2 O 4 9 BIS HA 195 c PDE II
82. B C 1 WER aI OREM E ARBRIT SAT FAL 2013 2011 2012 1 acute decompensated heart failure actvities of daily livings aortic insufficiency alanine aminotransferase activated partial thromboplastin time aortic regurgitation angiotensin Il receptor blocker aortic stenosis American Society for Artificial Internal Organs arteriosclerosis obliterans aspartate aminotransferase bispectral index body mass index brain natriuretic peptide bridge to bridge bridge to candidacy bridge to decision bridge to recovery bridge to transplantation biventricular assist device Centers for Disease Control and Prevention cardiac index chronic obstructive pulmonary disease C reactive protein cardiac resynchronization ther
83. 2014 4 33 89 2014 2 3 LVAD J MACS INTERMACS 2 3 1 INTERMACS LVAD BRL National Institute o
84. J MACS 3 J MACS 12 2010 6 11 114 J MACS 24 VAD VAD VAD VAD 749 VAD
85. 219 ASTM F1841 97 ISO 10993 4 ISO 14971 VAD 1998 ASAIO STS 5 2009 NationalClinicalTrial Initiative Reliability Subcommittee 19 VAD 7 80 confidence level 60 reliability
86. lla B T LVAD l Jv C 8 LVAD I C LVAD Ilb C 9 LVAD l C 10 BMI 30 40kg m2 VAD LVAD Ib B 11 LVAD 7 2A C 12 VAD VAD LL C
87. NYHA TIII EMPHASIS HF NYHA 7 TII 9 HA LVAD 2010 89 WERE OBM E VERICIT AT 2013 LAER amp HAA HESSE 72 C do CRT D CRT D QRS 120 msec 35 NYHA HI RAFT NYHA II QRS 150 msec CRT D LVAD
88. WER arm OREM E ARBRIT SAT FAL 2013 2011 2012 2 1 3 LVAD 2 0 mg dL HAH LVAD eGFR hANP V Na 09 NIP UY VEE CHA h
89. 4 1 2009 2011 EVAHEART DuraHeart 7 2 LVAD 2014 44 33 2011 AM LVAD LVAD LVAD 2014 1 300 in 2 WAW LVAD LVAD
90. d 2 e 9 m 3 4 3 4 1 LVAD LVAD A
91. 2 5 10 ASO TE Bi O BU E ACET SOA 2013 E HT M 2 5 11 VAD
92. LVAD Jarvik7 SyncardiaTAH LVAD BTT 2000 TE Bi JOE E AETR 2013 a Jarvik 2000 b HeartMate II X000000 c EVAHEART d DuraHeart e HVAD 2 Inlet Area Flow rate up to 2 5 Umin Actual Size A 9F 12F pump motor Outlet rea a Impella b TandemHeart Ed 3 WER aI OREM E ARBRIT SAT FAT 2013 2011 2012 a Jarvik 7 b AbioCor 4
93. VAD e Wd RAE 3 6 D LVAD backward PH pulmonary hypertention f YE E 7g 5 6 Wood T LVAD
94. PCPS tS U 3 AUS L VAD Profile 2 BTC BTC likely LVAD Profile 3 n HE LVAD Profile 4 k INTERMACS Profile 4 Profile 3 A Profile 4 Profile 4 WER aI OPE E ARBRIT SOT 2013 2011 2012
95. VAD S B n A VAD 225279 27 Borg 11
96. 25 BMI 8 cardiac cachexia c B reverse remodeling BNP JE ACE II ZRA ARB HA
97. Bae 259 LVAD 259720 3 1 5 AR II AR LVAD LVAD AR 261 263 AR 1 LVAD LVAD
98. 218 PAD VAD PAD VAD 219 VAD 09 VAD io
99. 5 Exertion intolerant 6 Exertion limited 7 Advanced NYHA III AHA ACC Stage A Stage B Stage c Stage DJ NYHA Ml IV INTERMACS J MACS 7654321 2 1 MEO E ABNF BAA FTT 2073 House bound Walking wounded 4 2010 11 16 3 amp 1 2 3 ZI BSA NYHA IIl IV IV D ACE BASSE ARB 6
100. PUN 3 Ho 2 CDC 4 fa Gram Gram Gram 245 240 b 1 3
101. 59 Doppler PFO 2 154155 PFO VSP b LVAD TEE b LVAD CORDS OMEN TV 152 ER Cy LVAD 1 1 2m sec 727 199 c de air
102. VAD deconditioning VAD LVAD M 280 22 _ VAD LVAD
103. Lower Shumway biatrial 303 bicaval E DAE bicaval 9 7 LVAD L bicaval bicaval 1 2 Joao FARIREBWS LK KGHR WA OMICS BRI ZEWEOSL KEIREWEL 3 FOMOWREAI CE DDS warm blood cardioplegia 3 4 2 LVAD LVAD reverse remo
104. LVAD 6 TE Beas ORM E BRIT SAL BAF 2013 2011 2012 6 HAL LVAD O 1 50 LVAD destination therapy DT B TE Bi JOE E ACET SOA 2013 BIT VAD B LVAD B
105. HeartMateVE REMATCH HeartMatell DT DT LVAD 25 DT BTC LVAD DT DT 29 bridge to bridge BTB LVAD VAD VAD VAD
106. 3 ACC AHA BY I TIII LVAD 2001 HeartMate VE REMATCH study Randomized Evaluation of Mechanical Assistance for the Treatment of Congestive Heart Failure 2009 HeartMate II DT DT 2 8 LVAD 23 96 LVAD 58 2002
107. d IABP PCPS ECMO VAD LVAD IABP VAD IABP IABP LVAD VAD VAD 97 bridge to decision BTD LVAD 9 PCPS
108. VAD 1 2 3 1 7 HAH LVAD LVAD VAD 326 20 X 18427
109. BVAD LVAD TR 19295 2 9 TR TAP 83 O LVAD HEOR 2 5 CVP gt 15 18mmHg LVAD 2 L min m Wink RVAD 59 2 P VAD Thoratec fl VAD VAD 2
110. LVAD AC DC 3 3 3 9 VAD RD 3 3 4 T PT INR XS PT INR
111. CT CT 1 alc 2 PT INR XS PT INR 3 3 3 5 LVAD LVAD
112. LVAD BB 3 LVAD 2011 2012 1 2013 AM LVAD LAL 199
113. VAD BIT DT DT nm 80 60 6 L 80 80 6 RB 2 m5 900 D VAD EW VAD VAD
114. 99 81mg 243mg 100 mg 300mg Du WER Gem OREM E ARBRIT EA FI 2013 2011 2012 RS VAD 1 1 6 12 2 3 6 CPX CDTI QOL SF 36 EuroQol MMSE TMT B
115. PT INR 2 0 2 5 2 3 3 HeartMate II 20 BIA TIA YES SIE Pere bt sk LZ 8 ix LAD I
116. 3 1 l 3 1 1 PT INR XS PTLINR PT INR 2 9 1 8 D CT D PT INR PCC K FFP
117. BVS 5000 ABIOMED AB5000 ABIOMED EXCOR Berlin Heart CentriMag Thoratec SynCardia Systems TAH SynCardia Systems AbioCor TAH ABIOMED Novacor LVAD WorldHeart HeartMate IP LVAD Thoratec Jarvik 2000 Jarvik Heart tt HeartMate II Thoratec tt EVAHEART DuraHeart HeartWare HVAD HeartWare TandemHeart CardiacAssist tt Impella ABIOMED PediPump Cleveland Clinic infant Jarvik Jarvik Heart tt PediaFlow VAD WorldHeart TE Beas JO REBEL CRIT SAA BAF 2013 gt 2011 2012 a VAD d AB 5000 e EXCOR 1 CentriMag LVAD VAD A VAD EXCOR Berlin 1 3 n DERAPE TSZ m L Heart 1e 1 2 x ig
118. QOL LVAD bridge to bridge 1 1 6 bridge to decision BTD VAD bridge to decision VAD temporary device TandemHeart Impella CentriMag 1 1 7 bridge to recovery BTR VAD reverse remodeling 3D BTR
119. 1919 100 VAD VAD EH Vm E p MRR OREM E ARBRIT SAT FI 2013 2011 2012 ll 7 am ile Li 1 1 VAD LVAD LVAD BTT
120. 79 Fontan GE 1 2 3 LVAD a BEE LVAD NYHA IV LVAD CRT AHA ACC Stage D INTERMACS Profile NYHA IV AHA ACC Stage D 3350 J MACS Profile 3 154 Profile 1 PCPS LVAD PCPS
121. 1 LVAD DT l B 4 CRT DT Ila C 5 VAD VAD VAD lla C VAD l C 6 LVAD
122. 99 f HE 50 7 Hi 41 2 59 10 VAD HEX ACE CRT HF B g
123. BTT BTR BTD DT LVAD 319 LVAD LVAD LVAD
124. 2 1 2 1 1 LVAD IABP VAD 79 VAD IABP 212 __ LVAD LVAD L
125. 2 2 1 LVAD 7 2 mm LVAD
126. 2012 41 81 85 288 McCahon D Fitzmaurice DA Murray ET et al SMART self management of anticoagulation a randomised trial ISRCTN 19313375 BMC Fam Pract 2003 4 11 289 Jackson SL Peterson GM Vial JH et al Improving the outcomes of anticoagulation an evaluation of home follow up of warfarin initiation J Intern Med 2004 256 137 144 290 Yang DT Robetorye RS Rodgers GM Home prothrombin time monitoring a literature analysis Am J Hematol 2004 77 177 186 291 Gardiner C Williams K Mackie IJ et al Patient self testing is a reliable and acceptable alternative to laboratory INR monitoring Br J Haematol 2005 128 242 247 292 Matchar DB Jacobson AK Edson RG et al The impact of patient self testing of prothrombin time for managing anticoagulation rationale and design of VA Cooperative Study 48 1 the Home INR Study THINRS J Thromb Thrombolysis 2005 19 163 172 293 Sobieraj Teague M Daniel D Farrelly B et al Accuracy and clinical usefulness of the CoaguChek S and XS Point of Care devices when starting warfarin in a hospital outreach setting Thromb Res 2009 123 909 913 294 Bhat D Upponi A Rakecha A et al Evaluating safety effectiveness and user satisfaction of home international normalized ratio monitoring service experience from a tertiary pediatric cardiology unit in the United Kingdom Pediatr Cardiol 2010 31 18 21 295 Dolor RJ Ruybalid RL Uyeda L et al An evaluati
127. TE Bi JOE E ACETA 2013 Interagency Registry for Mechanically Assisted Circulatory Support Japanese registry for Mechanically Assisted Circulatory Support The Japan Organ Transplant Network left anterior descending lactate dehydrogenase left ventricular assist device left ventricular assist system left ventricular end diastolic diameter left ventricular ejection fraction mitral insufficiency mitral regurgitation mitral stenosis National Heart Lung and Blood Institute nitric oxide New York Heart Association peripheral arterial disease prothrombin complex concentrate percutaneous cardiopulmonary support pulmonary capillary wedge pressure phosphodiesterase patent foramen ovale Pharmaceutical and Medical Devices Agency pulmonary regurgitation prothrombin time _ international normalized ratio quality of life right ventricular assist device Society of Thoracic Surgeons total artificial heart tricuspid annuloplasty transesophageal echocardiography tricuspid insufficiency tricuspid regurgitation ventricular assist device ventricular septal perforation 2 P pig
128. 281 MHS MR MR VAD BTR MR f VAD g TR LVAD JE TR TR DT h PR VAD PR
129. AbioCor TAH 2 LVAD 2A LVAD INTERMACS Profile 1 7 3 INTERMACS J MACS Profiles INTERMACS JJ_MACS 1 3 R3 INTERMACS Profile J MACS 1 VAD 2 3 LVAD 4 LVAD LVAD 2010 2010 11 16 G 4D ro LVAD
130. EH pu OF Ge pie LVAD BQ 2 LVAD Novacor LVAD HeartMate XVE LVAD 1200 16002 TandemHeart amp Impella LVAD 1 DuraHeart EVAHEART HeartMateIl 1 4 TEN x Jarvik 2000 HeartWare Ventricular Assist Device HVAD TAH TAH 4 1980
131. ICD CRT D 25 8 EEG EH VAD W SAAS b VAD
132. VAD 2 WITS VAD AbT bA VAD VAD 9 39 25
133. 5 PT INR i 2 0 3 0 2 5 3 0 133 134 LVAD VAD DS DuraHeart 9 EVAHEART FEE oD 9 LVAD VAD VAD HAH LVAD VAD LVAD VAD LVAD 2 3 7
134. CT D 2 5 12 VAD VAD MPR AIC Ko LDH fL LVAD VAD
135. HA 2 5 13 J MACS 2 3 5 mg dL 48 2 mg dL 90
136. HeartMate VE 2003 HeartMate XVE 2010 HeartMateII DT INTERMACS Registry J MACS Registry DT EBM HAR LVAD observationalstudy retrospective study historical control
137. 9 VAD 130mEq L Na 2 Na central pontine myelinolysis MEP CRER HA 1 Na 12mEq L Na 130mEq L pe MR OBM E ACETA FIY 2013 DSI PUY VRR CHS b IWIN 3 75 mg VAD C amp R RIC Na 108 21 6
138. TA LVAD 99 VAD p 3E HAD 63 WED 5 34 9 26 Becker 2005 29 Becker 15 4 Duchenne 3 3 Emery Dreifuss 1 1 83
139. 113 114 115 116 117 TE B PED LT E GRIEF EA 4 2013 119 120 12 122 124 125 126 127 128 129 130 13 132 133 134 135 136 137 138 139 140 Cool Seal system 2006 35 168 169 Sakaguchi T Matsumiya G Yoshioka D et al DuraHeartTM magnetically levitated left ventricular assist device Osaka University experience Circ J 2013 77 1736 1741 LVAD 2011 239 223 229 Westaby S Frazier OH Pigott DW et al Implant technique for the Jarvik 2000 Heart Ann Thorac Surg 2002 73 1337 1340 Frazier OH Myers TJ Gregoric ID et al Initial clinical experience with the Jarvik 2000 implantable axial flow left ventricular assist system Circulation 2002 105 2855 2860 3 Haj Yahia S Birks EJ Rogers P et al Midterm experience with the Jarvik 2000 axial flow left ventricular assist device J Thorac Cardiovasc Surg 2007 134 199 203 Frazier OH Implantation of the Jarvik 2000 left ventricular assist device without the use of cardiopulmonary bypass Ann Thorac Surg 2003 75 1028 1030 Tuzun E Gregoric ID Conger JL et al The effect of intermittent low speed mode upon aortic valve opening in calves supported wit
140. inflow cuff 18130 1310 2 HVAD 10 mm outflow graft HIE TA 93 28 HVAD 1800 rpm HVAD 2400 3200 rpm m CI 2L min m 20 APTT 40 60 sce
141. Profile 4 Profile 1 BTT 2 2 2 _ VAD VAD VAD BTD Profile 1 BTC Profile 2 49 2 2 Deos 221 VAD sous VAD INTERMACS 3545 25999 INTERMACS VAD 7 Profile 1 5 232 NYHAIV BE 6 7 23 HI REIS INTERMACS Profile 3 Profile 2
142. a KURA AS VAD b Al AT VAD E VAD VAD AI VAD AI VAD VAD 2 3 6 bridge to bridge VAD
143. 12 ARE TB REDDERE ARI PIT 504 FIT 203 147 2011 2012 T 1 48 1 e 148 2 e n 148 3 149 l rc 1 51 1 151 2 LVAD 154 1997 2 90 VAD BTT 2010 BTT 2004 Novacor LVAD 2
144. SBA EAE ABM AEIR Ge Sif A DON SAA STE ACT TAH GE VAD 2 2 1 1 paracorporeal VAD extracorporeal VAD VAD 1 2
145. VAD Profile 1 Profile 1 LVAD Profile 2 BTC VAD ICD Profile4 VAD DT LVAD INTERMACS Profile 2 Profile 3
146. 2 229 2 5 16 WT I T 9 2 5 17 T vo
147. 54 312 321 Kumar A Optimizing antimicrobial therapy in sepsis and septic shock Crit Care Clin 2009 25 733 751 viii Simon D Fischer S Grossman A et al Left ventricular assist device related infection treatment and outcome Clin Infect Dis 2005 40 1108 1115 Saito S Matsumiya G Sakaguchi T et al Fifteen year experience with Toyobo paracorporeal left ventricular assist system J Artif Organs 2009 12 27 34 Kawata M Nishimura T Hoshino Y et al Negative pressure wound therapy for left ventricular assist device related mediastinitis two case reports J Artif Organs 2011 14 159 162 3 Kinoshita O Nishimura T Kawata M et al Vacuum assisted closure with Safetac technology for mediastinitis in patients with a ventricular assist device J Artif Organs 2010 13 126 128 Kimura M Nishimura T Kinoshita O et al Successful Treatment of Pump Pocket Infection after Left Ventricular Assist Device Implantation by Negative Pressure Wound Therapy and Omental Transposition Ann Thorac Cardiovasc Surg 2013 Mar 26 Epub ahead of print Morito H Nishimura T Ando M et al Successful treatment of cerebral hemorrhage using computed tomography angiography in a patient with left ventricular assist device J Artif Organs 2012 15 90 93 Morito H Nishimura T Ando M et al Endovascular treatment of cerebral hemorrhage in a patient with a left ventricular assist device report of a case Surg Today 2013 May 16 Epub ahead of pri
148. ASAIO J 1998 44 108 114 Pantalos GM Altieri F Berson A et al Long term mechanical circulatory support system reliability recommendation American Society for Artificial Internal Organs and The Society of Thoracic Surgeons long term mechanical circulatory support system reliability recommendation Ann Thorac Surg 1998 66 1852 1859 Lee J Subcommittee NCTI Long term Mechanical Circulatory Support System reliability recommendation by the National Clinical Trial Initiative subcommittee ASAIO J 2009 55 534 542 Patel SM Throckmorton AL Untaroiu A et al The status of failure and reliability testing of artificial blood pumps ASAIO J 2005 51 440 451 AAA HSER VA RU ERRAR 2011 2011 46 537 541 AEVAHEART 2011 49 918 924 Kinugawa K How to treat stage D heart failure When to implant left ventricular assist devices in the era of continuous flow pumps Cire J 2011 75 2038 2045 Imamura T Kinugawa K Shiga T et al Novel risk scoring system with preoperative objective parameters gives a good prediction of 1 year mortality in patients with a left ventricular assist device Circ J 2012 76 1895 1903 Shiga T Kinugawa K Hatano M et al Age and preoperative total bilirubin level can stratify
149. LVAD TEE 7 Valsalva TEE LVAD 83 162 AD AT LVAD
150. considerations ASAIO J 2009 55 598 601 Gregoric ID Bruckner BA Jacob L et al Clinical experience with sternotomy versus subcostal approach for exchange of the HeartMate XVE to the HeartMate II ventricular assist device Ann Thorac Surg 2008 85 1646 1649 2012 http www j circ or jp guideline pdf JCS2012 nohara h pdf 2012 10 Morrone TM Buck LA Catanese KA et al Early progressive mobilization of patients with left ventricular assist devices is safe and optimizes recovery before heart transplantation J Heart Lung Transplant 1996 15 423 429 2011 http www circ or jp guideline pdf7 JCS2011 izumi h pdf 2012 10 Kurihara C Nishimura T Imanaka K et al Spontaneous increase in EVAHEART pump flow at a constant pump speed during exercise examination Ann Thorac Cardiovasc Surg 2012 18 514 518 Kugler C Malehsa D Tegtbur U et al Health related quality of life and exercise tolerance in recipients of heart transplants and left ventricular assist devices a prospective comparative study J Heart Lung Transplant 2011 30 204 210 Wilson SR Givertz MM Stewart GC
151. et al Transesophageal contrast echocardiography and color flow mapping methods of choice for the detection of shunts at the atrial level Am Heart J 1992 124 1545 1550 Sun JP Stewart WJ Hanna J et al Diagnosis of patent foramen ovale by contrast versus color Doppler by transesophageal echocardiography relation to atrial size Am Heart J 1996 131 239 244 Gologorsky E Gologorsky A Pham SM Monitoring of aortic valve opening and systolic aortic insufficiency in optimization of continuous flow left ventricular assist device settings J Cardiothorac Vasc Anesth 2012 26 1063 1066 Catena E Tasca G Role of echocardiography in the perioperative management of mechanical circulatory assistance Best Pract Res Clin Anaesthesiol 2012 26 199 216 Vitebskiy S Fox K Hoit BD Routine transesophageal echocardiography for the evaluation of cerebral emboli in elderly patients Echocardiography 2005 22 770 774 Glas KE Swaminathan M Reeves ST et al Guidelines for the performance of a comprehensive intraoperative epiaortic ultrasonographic examination recommendations of the American Society of Echocardiography and the Society of Cardiovascular Anesthesiologists endorsed by the Society of Thoracic Surgeons Anesth Analg 2008 106 1376 1384 George RS Sabharwal NK Webb C et al Echocardiographic assessment of flow across continuous flow ventricular assist devices at low speeds J Heart Lung Transplant 2010 29 1245 1252 Hor
152. et al Ventricular assist devices the challenges of outpatient management J Am Coll Cardiol 2009 54 1647 1659 2003 10 240 Heart 2012 2 640 647 3 Marcuccilli L Casida JJ Overcoming alterations in body image imposed by the left ventricular assist device a case report Prog Transplant 2012 22 1 216 Heart 2012 2 67 74 Marcuccilli L Casida JM From insiders perspectives adjusting to caregiving for patients with left ventricular assist devices Prog Transplant 2011 21 137 143 WER ae OREM E ARBRIT SAL 2013 2011 2012 286 Fey O El Banayosy A Arosuglu L et al Out of hospital experience in patients with implantable mechanical circulatory support present and future trends Eur J Cardiothorac Surg 1997 11 S51 53 287 KERIB FZ HA A TURO PVAHEARTTM
153. 6 228 240 Huttner HB Schellinger PD Hartmann M et al Hematoma growth and outcome in treated neurocritical care patients with intracerebral hemorrhage related to oral anticoagulant therapy comparison of acute treatment strategies using vitamin K fresh frozen plasma and prothrombin complex concentrates Stroke 2006 37 1465 1470 3 Kormos L Holman W Chapter 13 Adverse events and complications of mechanical circulatory support In Kormos RL Miller LW editors Mechanical circulatory support a companion to Braunwald s heart disease Elsevier Saunders 2012 166 182 Garner JS Jarvis WR Emori TG et al CDC definitions for nosocomial infections 1988 Am J Infect Control 1988 16 128 140 Gordon SM Schmitt SK Jacobs M et al Nosocomial bloodstream infections in patients with implantable left ventricular assist devices Ann Thorac Surg 2001 72 725 730 Toda K Yonemoto Y Fujita T et al Risk analysis of bloodstream infection during long term left ventricular assist device support Ann Thorac Surg 2012 94 1387 1393 Holman WL Fix RJ Foley BA et al Management of wound and left ventricular assist device pocket infection Ann Thorac Surg 1999 68 1080 1082 Matsumiya G Nishimura M Miyamoto Y et al Successful treatment of Novacor pump pocket infection by omental transposition Ann Thorac Surg 2003 75 287 288 Nurozler F Argenziano M Oz MC et al Fungal left ventricular assist device endocarditis Ann Thorac
154. Andersen CB Mortensen SA et al Cardiac sarcoidosis and heart transplantation a report of four consecutive patients Sarcoidosis Vasc Diffuse Lung Dis 2008 25 51 59 Ward KM Binns H Chin C et al Pediatric heart transplantation for anthracycline cardiomyopathy cancer recurrence is rare J Heart Lung Transplant 2004 23 1040 1045 2009 http 2012 10 Cooper LT Berry GJ Shabetai R Idiopathic giant cell myocarditis natural history and treatment Multicenter Giant Cell Myocarditis Study Group Investigators N Engl J Med 1997 336 1860 1866 Wu RS Gupta S Brown RN et al Clinical outcomes after cardiac transplantation in muscular dystrophy patients J Heart Lung Transplant 2010 29 432 438 Arnaoutakis GJ George TJ Kilic A et al Risk factors for early death in patients bridged to transplant with continuous flow left ventricular assist devices Ann Thorac Surg 2012 93 1549 1554 discussion 1555 http www jotnw or jp Jones RH Velazquez EJ Michler RE et al Coronary bypass surgery with or without surgical ventricular reconstruction N Engl J Med 2009 360 1705 1717 Bunch TJ Mahapatra S Madhu Reddy Y et al The role of percutaneous left ventricular assist devices during ventricular tachycardia ablation Europace 2
155. Fontan procedure Tex Heart Inst J 2005 32 402 404 Humpl T Furness S Gruenwald C et al The Berlin Heart EXCOR Pediatrics The SickKids Experience 2004 2008 Artif Organs 2010 34 1082 1086 Imamura M Dossey AM Prodhan P et al Bridge to cardiac transplant in children Berlin Heart versus extracorporeal membrane oxygenation Ann Thorac Surg 2009 87 1894 1901 discussion 1901 VanderPluym CJ Rebeyka IM Ross DB et al The use of ventricular assist devices in pediatric patients with univentricular hearts J Thorac Cardiovasc Surg 2011 141 588 590 Clark JB Pauliks LB Myers JL et al Mechanical circulatory support for end stage heart failure in repaired and palliated congenital heart disease Curr Cardiol Rev 2011 7 102 109 Stevenson LW Pagani FD Young JB et al INTERMACS profiles of advanced heart failure the current picture J Heart Lung Transplant 2009 28 535 541 Imamura T Kinugawa K Shiga T et al Early decision for a left ventricular assist device implantation is necessary for patients with modifier A J Artif Organs 2012 15 301 304 Slaughter MS Pagani FD Rogers JG et al Clinical management of continuous flow left ventricular assist devices in advanced heart failure J Heart Lung Transplant 2010 29 S1 39 Rogers JK McMurray JJ Pocock SJ et al Eplerenone in patients with systolic heart failure and mild symptoms analysis of repeat hospitalizations Circulation 2012 126 2317 2323
156. Plast Reconstr Surg 2011 128 498e 503e Shiotani A Sakakibara T Yamanaka Y et al Upper gastrointestinal ulcer in Japanese patients taking low dose aspirin J Gastroenterol 2009 44 126 131 Meyer MM Young SD Sun B et al Endoscopic evaluation and management of gastrointestinal bleeding in patients with ventricular assist devices Gastroenterol Res Pract 2012 2012 630483 Elmunzer BJ Padhya KT Lewis JJ et al Endoscopic findings and clinical outcomes in ventricular assist device recipients with gastrointestinal bleeding Dig Dis Sci 2011 56 3241 3246 el Amir NG Gardocki M Levin HR et al Gastrointestinal consequences of left ventricular assist device placement ASAIO J 1996 42 150 153 Herman SC Muehlschlegel JD Couper GS et al Colonic perforation from left ventricular assist device a rare complication Interact Cardiovasc Thorac Surg 2010 11 369 370 Yannopoulos D Subacute gastric perforation caused by a left ventricular assist device World J Gastroenterol 2007 13 3253 3254 3 Naitoh T Morikawa T Sakata N et al Emergency laparoscopic cholecystectomy for a patient with an implantable left ventricular assist device report of a case Surg Today 2013 43 313 316 Sathishkumar S Kodavatiganti R Plummer S et al Perioperative management of a patient with an axial flow rotary ventricular assist device for laparoscopic ileo colectomy J Anaesthesiol Clin Pharmacol 2012 28 101 105
157. post transplant mortality Ann Thorac Surg 2004 77 859 863 Stevenson LW Patient selection for mechanical bridging to transplantation Ann Thorac Surg 1996 61 380 387 discussion 391 382 Schaffer JM Allen JG Weiss ES et al Infectious complications after pulsatile flow and continuous flow left ventricular assist device implantation J Heart Lung Transplant 2011 30 164 174 Malani PN Dyke DB Pagani FD et al Nosocomial infections in left ventricular assist device recipients Clin Infect Dis 2002 34 1295 1300 Perme CS Southard RE Joyce DL et al Early mobilization of LVAD recipients who require prolonged mechanical ventilation Tex Heart Inst J 2006 33 130 133 Smedira NG Wudel JH Hlozek CC et al Venovenous extracorporeal life support for patients after cardiotomy ASAIO J 1997 43 M444 446 Wudel JH Hlozek CC Smedira NG et al Extracorporeal life support as a post left ventricular assist device implant supplement ASAIO J 1997 43 M441 443 Pagani FD Aaronson KD Swaniker F et al The use of extracorporeal life support in adult patients with primary cardiac failure as a bridge to implantable left ventricular assist device Ann Thorac Surg 2001 71 S77 81 discussion S82 75 Lippi G Franchini M Home monitoring of warfarin effects N Engl J Med 2011 364 378 author reply 378 379 Suissa D Danino A Nikolis A Negative pressure therapy versus standard wound care a meta analysis of randomized trials
158. prognosis after extracorporeal pulsatile left ventricular assist device implantation Cire J 2011 75 121 128 Imamura T Kinugawa K Shiga T et al How to demonstrate the reversibility of end organ function before implantation of left ventricular assist device in INTERMACS profile 2 patients J Artif Organs 2012 15 395 398 Russell SD Rogers JG Milano CA et al Renal and hepatic function improve in advanced heart failure patients during continuous flow support with the HeartMate II left ventricular assist device Circulation 2009 120 2352 2357 Kirklin JK Naftel DC Kormos RL et al The Fourth INTERMACS Annual Report 4 000 implants and counting J Heart Lung Transplant 2012 31 117 126 Imamura T Kinugawa K Shiga T et al Preoperative levels of bilirubin or creatinine adjusted by age can predict their reversibility WEB EAL 2013 33 34 40 4 pars 42 43 45 46 47 48 Khot UN Mishra M Yamani MH et al Severe renal dysfunction complicating cardiogenic shock is not a contraindication to mechanical support as a bridge to cardiac transplantation J Am Coll Cardiol 2003 41 381 385 Kashiwa K Nishimura T Saito A et al Left heart bypass support with the Rotaflow Centrifugal Pump as a bridge to decision and recovery in an adult J Artif Organs 2012 15 207 210 Drakos SG Kfoury AG Stehlik J et al Bridge to recovery understanding the disconnect betwee
159. the heart J Thorac Cardiovasc Surg 1961 41 196 204 304 Aziz T Burgess M Khafagy R et al Bicaval and standard techniques in orthotopic heart transplantation medium term experience in cardiac performance and survival J Thorac Cardiovasc Surg 1999 118 115 122 305 Kitamura S Nakatani T Kato T et al Hemodynamic and echocardiographic evaluation of orthotopic heart transplantation with the modified bicaval anastomosis technique Circ J 2009 73 1235 1239 306 Levin HR Oz MC Chen JM et al Reversal of chronic ventricular dilation in patients with end stage cardiomyopathy by prolonged mechanical unloading Circulation 1995 91 2717 2720 307 Frazier OH Myers TJ Left ventricular assist system as a bridge to myocardial recovery Ann Thorac Surg 1999 68 734 741 308 Klotz S Barbone A Reiken S et al Left ventricular assist device support normalizes left and right ventricular beta adrenergic IFRI O BW E GIL LAT EOL 2013 309 310 311 312 313 314 315 316 317 318 319 320 321 pathway properties J Am Coll Cardiol 2005 45 668 676 Mancini DM Beniaminovitz A Levin H et al Low incidence of myocardial recovery after left ventricular assist device implantation in patients with chronic heart failure Circulation 1998 98 2383 2389 Maybaum S Mancini D Xydas S et al Cardiac improvement during mechanical circulatory support a prospective multicen
160. 0 LVAD BTT 2002 FDA destination therapy DT 2011 LVAD BTT 2013 DT LVAD LVAD DT 10 LVAD i LVAD 2012
161. 009 87 1072 1078 Reedy JE Swartz MT Termuhlen DF et al Bridge to heart transplantation importance of patient selection J Heart Transplant 1990 9 473 480 discussion 480 471 Yoshioka D Sakaguchi T Saito S et al Predictor of early mortality for severe heart failure patients with left ventricular assist device implantation significance of INTERMACS level and renal function Circ J 2012 76 1631 1638 Miller LW Patient selection for the use of ventricular assist devices as a bridge to transplantation Ann Thorac Surg 2003 75 S66 71 Farrar DJ Preoperative predictors of survival in patients with Thoratec ventricular assist devices as a bridge to heart transplantation Thoratec Ventricular Assist Device Principal Investigators J Heart Lung Transplant 1994 13 93 100 discussion 100 101 Oz MC Goldstein DJ Pepino P et al Screening scale predicts patients successfully receiving long term implantable left ventricular assist devices Circulation 1995 92 II169 173 Hasin T Topilsky Y Schirger JA et al Changes in renal function after implantation of continuous flow left ventricular assist devices J 188 189 190 191 192 194 195 196 197 198 199 200 201 202 204 205 206 207 208 209 210 TE B PED SEE E REBT EA 4 2013 211 212 213 214 215 216 217 218 219 220 22 222 223 224 22
162. 012 14 Suppl 2 ii26 ii32 Lamour JM Kanter KR Naftel DC et al The effect of age diagnosis and previous surgery in children and adults undergoing heart transplantation for congenital heart disease J Am Coll Cardiol 2009 54 160 165 Duncan BW Fukamachi K Noble LD et al The PediPump a versatile implantable pediatric ventricular assist device update IV Artif Organs 2009 33 1005 1008 Gibber M Wu ZJ Chang WB et al In vivo experience of the child size pediatric Jarvik 2000 heart update ASAIO J 2010 56 369 376 Maul TM Kocyildirim E Johnson CA et al In Vitro and In Vivo Performance Evaluation of the Second Developmental Version of the 74 75 76 TI 78 79 80 8 82 83 84 85 86 87 88 89 90 9 92 93 94 95 96 PediaFlow Pediatric Ventricular Assist Device Cardiovasc Eng Technol 2011 2 253 262 Inoue T Nishimura T Murakami A et al Four year paracorporeal left ventricular assist device LVAD support for heart failure after Rastelli operation J Artif Organs 2013 Lowry AW Adachi I Gregoric ID et al The potential to avoid heart transplantation in children outpatient bridge to recovery with an intracorporeal continuous flow left ventricular assist device in a 14 year old Congenit Heart Dis 2012 7 E91 96 Frazier OH Gregoric ID Messner GN Total circulatory support with an LVAD in an adolescent with a previous
163. 13 ADL VAD VAD 4 amp 4 289 LVAD 8 QOL T9
164. 15 141 149 Smith V Sun B Lindsey D et al Surgical management of unusual gastrointestinal bleeding and a left ventricular assist device Interact Cardiovasc Thorac Surg 2010 11 612 613 Uriel N Pak SW Jorde UP et al Acquired von Willebrand syndrome after continuous flow mechanical device support contributes to a high prevalence of bleeding during long term support 261 262 264 265 266 267 268 269 270 271 272 273 274 235 276 277 278 279 280 281 282 284 285 and at the time of transplantation J Am Coll Cardiol 2010 56 1207 1213 Toda K Fujita T Domae K et al Late aortic insufficiency related to poor prognosis during left ventricular assist device support Ann Thorac Surg 2011 92 929 934 Cowger J Pagani FD Haft JW et al The development of aortic insufficiency in left ventricular assist device supported patients Circ Heart Fail 2010 3 668 674 3 Pak SW Uriel N Takayama H et al Prevalence of de novo aortic insufficiency during long term support with left ventricular assist devices J Heart Lung Transplant 2010 29 1172 1176 Letsou GV Connelly JH Delgado RM et al Is native aortic valve commissural fusion in patients with long term left ventricular assist devices associated with clinically important aortic insufficiency J Heart Lung Transplant 2006 25 395 399 Westaby S Bertoni GB Clelland C et al Circulatory suppor
165. 2014 4 28 2011 2012 Guidelines for Device Therapy Implantable Left Ventricular Assist Device for Patients with Severe Heart Failure JCS JSCVS2013 i ir HE BRAN ad
166. 5 226 227 228 229 230 234 Am Coll Cardiol 2012 59 26 36 Demirozu ZT Etheridge WB Radovancevic R et al Results of HeartMate II left ventricular assist device implantation on renal function in patients requiring post implant renal replacement therapy J Heart Lung Transplant 2011 30 182 187 Quan A Quigley R Renal replacement therapy and acute renal failure Curr Opin Pediatr 2005 17 205 209 Bart BA Boyle A Bank AJ et al Ultrafiltration versus usual care for hospitalized patients with heart failure the Relief for Acutely Fluid Overloaded Patients With Decompensated Congestive Heart Failure RAPID CHP trial J Am Coll Cardiol 2005 46 2043 2046 Costanzo MR Guglin ME Saltzberg MT et al Ultrafiltration versus intravenous diuretics for patients hospitalized for acute decompensated heart failure J Am Coll Cardiol 2007 49 675 683 Dang NC Topkara VK Mercando M et al Right heart failure after left ventricular assist device implantation in patients with chronic congestive heart failure J Heart Lung Transplant 2006 25 1 6 Kavarana MN Pessin Minsley MS Urtecho J et al Right ventricular dysfunction and organ failure in left ventricular assist device recipients a continuing problem Ann Thorac Surg 2002 73 745 750 Morgan JA John R Lee BJ et al Is severe right ventricular failure in left ventricular assist device recipients a risk factor for unsuccessful bridging to transplant and
167. DR AEL LVAD CT LVAD LVAD LVAD Wee LVAD LVAD
168. E Miller DA Hoagland PM et al Assessment of recurrent heart failure associated with left ventricular assist device dysfunction J Heart Lung Transplant 2005 24 2060 2067 Cohn WE Gregoric ID Frazier OH Reinforcement of left ventricular assist device outflow grafts to prevent kinking Ann Thorac Surg 2007 84 301 302 Jafar M Gregoric ID Radovancevic R et al Urgent exchange of a HeartMate II left ventricular assist device after percutaneous lead fracture ASAIO J 2009 55 523 524 Lietz K Long JW Kfoury AG et al Outcomes of left ventricular assist device implantation as destination therapy in the post REMATCH era implications for patient selection Circulation 2007 116 497 505 Topkara VK Dang NC Barili F et al Predictors and outcomes of continuous veno venous hemodialysis use after implantation of a left ventricular assist device J Heart Lung Transplant 2006 25 404 408 WER ae IG OREM E ARBRIT SAL FIL 2013 2011 2012 4 E 187 Pawar M Mehta Y Kapoor P et al Central venous catheter related blood stream infections incidence risk factors outcome and associated pathogens J Cardiothorac Vasc Anesth 2004 18 304 308 Pagani FD Miller LW Russell SD et al Extended mechanical circulatory support with a continuous flow rotary left ventricular assist device J Am Coll Cardiol 2009
169. PJS mE PJS FH WER aI OREM E ARBRIT SAT 2013 gt 2011 2012 1 Yamane T Kyo S Matsuda H et al Japanese guidance for after implantation of left ventricular assist device Circ J 2013 77 ventricular assist devices total artificial hearts Artif Organs 2010 96 104 34 699 702 27 Yamakawa M Kyo S Yamakawa S et al Destination therapy the 2 Rose EA Gelijns AC Moskowitz AJ et al Long term use of a left new gold standard treatment for heart failure patients with left ventricular assist device for end stage heart failure N Engl J Med ventricular assist devices Gen Thorac Cardiovasc Surg 2013 61 2001 345 1435 1443 111 117 3 Slaughter MS Rogers JG Milano CA et al Advanced heart failure 28 Kirklin JK Naftel DC Pagani FD et al Long term mechanical treated with continuous flow left ventricular assist device N Engl J circulatory support destination therapy on track to compete with Med 2009 361 2241 2251 heart transplantation J Thorac Cardiovasc Surg 2012 144 4 Vranckx P Foley DP de Feijter PJ et al Clinical introduction of the 584 603 discussion 597 588 a 14 18 19 20 2 22 23 24 25 26 Wi Bt as i DRE Tandemheart a percutaneous left ven
170. Surg 2001 71 614 618 Poston RS Husain S Sorce D et al LVAD bloodstream infections therapeutic rationale for transplantation after LVAD infection J Heart Lung Transplant 2003 22 914 921 Schulman AR Martens TP Russo MJ et al Effect of left ventricular assist device infection on post transplant outcomes J Heart Lung Transplant 2009 28 237 242 Imamura T Kinugawa K Shiga T et al A case of late onset right ventricular failure after implantation of a continuous flow left ventricular assist device J Artif Organs 2012 15 200 203 Topilsky Y Oh JK Shah DK et al Echocardiographic predictors of adverse outcomes after continuous left ventricular assist device implantation JACC Cardiovasc Imaging 2011 4 211 222 Crow S John R Boyle A et al Gastrointestinal bleeding rates in recipients of nonpulsatile and pulsatile left ventricular assist devices J Thorac Cardiovasc Surg 2009 137 208 215 Massyn MW Khan SA Heyde syndrome a common diagnosis in older patients with severe aortic stenosis Age Ageing 2009 38 267 270 discussion 251 Slaughter MS Hematologic effects of continuous flow left ventricular assist devices J Cardiovasc Transl Res 2010 3 618 624 Vincentelli A Susen S Le Tourneau T et al Acquired von Willebrand syndrome in aortic stenosis N Engl J Med 2003 349 343 349 Mohri H Acquired von Willebrand syndrome its pathophysiology laboratory features and management J Thromb Thrombolysis 2003
171. VAD LVAD LVAD BTC BTC 40 INTERMACS BTC 3 likely moderately likely unlikely LVAD 79 114 __ destination therapy DT LVAD 229 LVAD DT
172. VAD LVAD RVAD LVAD RVAD BVAD VAD Elia VAD AB5000 1d BTT VAD 30 2011 DuraHeart EVAHEART VAD BTT VAD VAD
173. agement of aortic insufficiency with continuous flow left ventricular assist devices bioprosthetic valve replacement J Heart Lung Transplant 2006 25 1410 1412 Park SJ Liao KK Segurola R et al Management of aortic insufficiency in patients with left ventricular assist devices a simple coaptation stitch method Park s stitch J Thorac Cardiovasc Surg 2004 127 264 266 Maltais S Topilsky Y Tchantchaleishvili V et al Surgical treatment of tricuspid valve insufficiency promotes early reverse remodeling in patients with axial flow left ventricular assist devices J Thorac Cardiovasc Surg 2012 143 1370 1376 Piacentino V Williams ML Depp T et al Impact of tricuspid valve regurgitation in patients treated with implantable left ventricular assist devices Ann Thorac Surg 2011 91 1342 1346 discussion 1346 1347 Saeed D Kidambi T Shalli S et al Tricuspid valve repair with left ventricular assist device implantation is it warranted J Heart Lung WER ae IG OREM E ARBRIT SAT 2013 2011 2012 4 E Transplant 2011 30 530 535 Rao V Slater JP Edwards NM et al Surgical management of valvular disease in patients requiring left ventricular assist device support Ann Thorac Surg 2001 71 1448 1453 Tasset MR Kavarana MN Gray LA et al Simple mechanical aortic valve c
174. apy cardiac resynchronization therapy defibrillator cardiothoracic ratio central venous pressure destination therapy evidence based medicine extracorporeal membrane oxygenation ejection fraction estimated glomerular filtration rate fresh frozen plasma human atrial natriuretic peptide intra aortic balloon pumping implantable cardioverter defibrillator intermittent low speed Jm I ASMP AE SIMA EE PITA ES D OU E C Ae s SF I zm
175. deling v LVAD bridgetorecovery reverse remodeling 30 3 reverse remodeling 2 X 4 LVAD 1 13 3319 LVAD 3 LVAD LVAD HBR IMR B ACB i Harefield recovery protocol 39 LVAD Berlin 3 LVAD LVEF ARIMR 45 LVEDD 55 mm OB WER aI OREM E ARBRIT SAT FAL 2013
176. e diagnosis and treatment of acute and chronic heart failure and the 2007 ESC guidelines for cardiac and resynchronization therapy Developed with the special contribution of the Heart Failure Association and the European Heart Rhythm Association Eur Heart J 2010 31 2677 2687 McMurray JJ Adamopoulos S Anker SD et al ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012 The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology Developed in collaboration with the Heart Failure Association HFA of the ESC Eur Heart J 2012 33 1787 1847 Heart Failure Society Of America HFSA 2010 Comprehensive Heart Failure Practice Guideline Section 10 Surgical Approaches to the Treatment of Heart Failure J Card Fail 2010 16 e122 125 Stulak JM Cowger J Haft JW et al Device exchange after primary left ventricular assist device implantation indications and outcomes Ann Thorac Surg 2013 95 1262 1267 discussion 1267 1268 Yamazaki K Saito S Kihara S et al Completely pulsatile high flow circulatory support with a constant speed centrifugal blood pump mechanisms and early clinical observations Gen Thorac Cardiovasc Surg 2007 55 158 162 118 BVAHEART 97 98 99 100 101 102 104 105 106 107 108 109 110 11 112
177. et al Alternative technique of right sided outflow cannula insertion for right ventricular support Ann Thorac Surg 1998 66 1829 1830 Schlensak C Schibilsky D Siepe M et al Biventricular cannulation is superior regarding hemodynamics and organ recovery in patients on biventricular assist device support J Heart Lung Transplant 2011 30 1011 1017 Fukui S Matsumiya G Toda K et al Recovery from hemorrhagic pulmonary damage by combined use of a left ventricular assist system and right ventricular assist system and extracorporeal membrane oxygenation J Heart Lung Transplant 2006 25 248 250 Miller LW Pagani FD Russell SD et al HeartMate II Clinical Investigators Use of a continuous flow device in patients awaiting heart transplantation N Engl J Med 2007 357 885 896 Morshuis M El Banayosy A Arusoglu L et al European experience of DuraHeart magnetically levitated centrifugal left ventricular assist system Eur J Cardiothorac Surg 2009 35 1020 1027 discussion 1027 1028 3 Cleveland JC Naftel DC Reece TB et al Survival after biventricular assist device implantation an analysis of the Interagency Registry for Mechanically Assisted Circulatory Support database J Heart Lung Transplant 2011 30 862 869 Fitzpatrick JR Frederick JR Hiesinger W et al Early planned institution of biventricular mechanical circulatory support results in improved outcomes compared with delayed conversion of a left ventricular a
178. f Health Food and Drug Administration Centers for Medicare and Medicaid Services National Heart Lung and Blood Institute NHLBD The University of Alabama at Birmingham Interagency Registry for Mechani cally Assisted Circulatory Support INTERMACS 2006 2013 3 6 5000 Profile 2 3 2 J MACS AM LVAD 2008 6 1 PMDA J MACS Japanese registry for Mechanically Assisted Circulatory Support
179. h a Jarvik 2000 axial flow device ASAIO J 2005 51 139 143 Nawata K Nishimura T Kyo S et al Outcomes of midterm circulatory support by left ventricular assist device implantation with descending aortic anastomosis J Artif Organs 2010 13 197 201 Sorensen EN Pierson RN Feller ED et al University of Maryland surgical experience with the Jarvik 2000 axial flow ventricular assist device Ann Thorac Surg 2012 93 133 140 Slaughter MS Implantation of the HeartWare left ventricular assist device Semin Thorac Cardiovasc Surg 2011 23 245 247 Cheung A Lamarche Y Kaan A et al Off pump implantation of the HeartWare HVAD left ventricular assist device through minimally invasive incisions Ann Thorac Surg 2011 91 1294 1296 Strueber M O Driscoll G Jansz P et al HeartWare Investigators Multicenter evaluation of an intrapericardial left ventricular assist system J Am Coll Cardiol 2011 57 1375 1382 Dell Aquila AM Schneider SR Schlarb D et al Initial clinical experience with the HeartWare left ventricular assist system a single center report Ann Thorac Surg 2013 95 170 177 Gregoric ID Cohn WE Frazier OH Diaphragmatic implantation of the HeartWare ventricular assist device J Heart Lung Transplant 2011 30 467 470 Aaronson KD Slaughter MS Miller LW et al HeartWare Ventricular Assist Device HVAD Bridge to Transplant ADVANCE Trial Investigators Use of an intrapericardial continuous flow centrifugal pum
180. losure in ventricular assist device recipients Ann Thorac Surg 2006 82 316 318 Adamson RM Dembitsky WP Baradarian S et al Aortic valve closure associated with HeartMate left ventricular device support technical considerations and long term results J Heart Lung Transplant 2011 30 576 582 Swartz MT Lowdermilk GA Moroney DA et al Ventricular assist device support in patients with mechanical heart valves Ann Thorac Surg 1999 68 2248 2251 Tisol WB Mueller DK Hoy FB et al Ventricular assist device use with mechanical heart valves an outcome series and literature review Ann Thorac Surg 2001 72 2051 2054 discussion 2055 Matsumiya G Miyamoto Y Monta O et al Left ventricular restoration for ischemic cardiomyopathy and simultaneous implantation of left ventricular assist system actively aiming at bridge to recovery J Thorac Cardiovasc Surg 2005 130 219 220 3 Takeda K Ahmad U Malaisrie SC et al Successful implantation of HeartWare HVAD left ventricular assist device with concomitant ascending and sinus of valsalva aneurysms repair J Artif Organs 2012 15 204 206 Block CA Manning HL Prevention of acute renal failure in the critically ill Am J Respir Crit Care Med 2002 165 320 324 Konstam MA Gheorghiade M Burnett JC et al Efficacy of Vasopressin Antagonism in Heart Failure Outcome Study With Tolvaptan EVEREST Investigators Effects of oral tolvaptan in patients hospitalized for worsening heart failu
181. n and tissue oxygenation Br J Anaesth 2009 103 Suppl 1 13 13 Horwitz LD Effects of intravenous anesthetic agents on left ventricular function in dogs Am J Physiol 1977 232 H44 48 3 Ruetzler K Grubhofer G Schmid W et al Randomized clinical trial comparing double lumen tube and EZ Blocker for single lung ventilation Br J Anaesth 2011 106 896 902 Ballester M Llorens J Garcia de la Asuncion J et al Myocardial 145 146 147 148 149 150 151 152 153 154 155 156 157 158 159 160 16 eB 162 164 165 oxidative stress protection by sevoflurane vs propofol a randomised controlled study in patients undergoing off pump coronary artery bypass graft surgery Eur J Anaesthesiol 2011 28 874 881 Greco M Landoni G Biondi Zoccai G et al Remifentanil in cardiac surgery a meta analysis of randomized controlled trials J Cardiothorac Vasc Anesth 2012 26 110 116 Nussmeier NA Probert CB Hirsch D et al Anesthetic management for implantation of the Jarvik 2000 left ventricular assist system Anesth Analg 2003 97 964 971 table of contents Miller RD editor Miller s Anesthesia 7th ed Churchill Livingstone 2010 Morales DL Gregg D Helman DN et al Arginine vasopressin in the treatment of 50 patients with postcardiotomy vasodilatory shock A
182. n clinical and biological outcomes Circulation 2012 126 230 241 Matsumiya G Monta O Fukushima N et al Who would be a candidate for bridge to recovery during prolonged mechanical left ventricular support in idiopathic dilated cardiomyopathy J Thorac Cardiovasc Surg 2005 130 699 704 Nishimura T Kyo S High dose carvedilol therapy for mechanical circulatory assisted patients J Artif Organs 2010 13 88 91 Kurihara C Nishimura T Nawata K et al Successful bridge to recovery with VAD implantation for anthracycline induced cardiomyopathy J Artif Organs 2011 14 249 252 Birks EJ Tansley PD Hardy J et al Left ventricular assist device and drug therapy for the reversal of heart failure N Engl J Med 2006 355 1873 1884 Nishimura T Kyo S Triple site pacing a new supported therapy approach for bridge to recovery with a left ventricular assist system in a patient with idiopathic dilated cardiomyopathy J Artif Organs 2010 13 54 57 JEE As vr D 2005 2007 http www circ_or jp guideline pdf JCS2007 doi h pdf 2012 10
183. nn Thorac Surg 2000 69 102 106 Society of Thoracic Surgeons Blood Conservation Guideline Task Force Ferraris VA Brown JR et al 2011 update to the Society of Thoracic Surgeons and the Society of Cardiovascular Anesthesiologists blood conservation clinical practice guidelines Ann Thorac Surg 2011 91 944 982 Society of Thoracic Surgeons Blood Conservation Guideline Task Force Ferraris VA Ferraris SP et al Perioperative blood transfusion and blood conservation in cardiac surgery the Society of Thoracic Surgeons and The Society of Cardiovascular Anesthesiologists clinical practice guideline Ann Thorac Surg 2007 83 S27 86 American Society of Anesthesiologists and Society of Cardiovascular Anesthesiologists Task Force on Transesophageal Echocardiography Practice guidelines for perioperative transesophageal echocardiography An updated report by the American Society of Anesthesiologists and the Society of Cardiovascular Anesthesiologists Task Force on Transesophageal Echocardiography Anesthesiology 2010 112 1084 1096 Chumnanvej S Wood MJ MacGillivray TE et al Perioperative echocardiographic examination for ventricular assist device implantation Anesth Analg 2007 105 583 601 Shapiro GC Leibowitz DW Oz MC et al Diagnosis of patent foramen ovale with transesophageal echocardiography in a patient supported with a left ventricular assist device J Heart Lung Transplant 1995 14 594 597 de Belder MA Tourikis L Griffith M
184. nsion phase Eur Heart J 2006 27 1928 1932 Bolling SF Pagani FD Deeb GM et al Intermediate term outcome of mitral reconstruction in cardiomyopathy J Thorac Cardiovasc Surg 1998 115 381 386 discussion 387 388 Franco Cereceda A McCarthy PM Blackstone EH et al Partial left ventriculectomy for dilated cardiomyopathy is this an alternative to 49 50 5 22 53 54 35 56 2T 58 59 60 6 62 63 64 65 66 67 68 69 70 vi 32 73 transplantation J Thorac Cardiovasc Surg 2001 121 879 893 Isomura T Suma H Horii T et al Left ventricle restoration in patients with non ischemic dilated cardiomyopathy risk factors and predictors of outcome and change of mid term ventricular function Eur J Cardiothorac Surg 2001 19 684 689 Suma H Tanabe H Uejima T et al Selected ventriculoplasty for idiopathic dilated cardiomyopathy with advanced congestive heart failure midterm results and risk analysis Eur J Cardiothorac Surg 2007 32 912 916 Matsui Y Fukada Y Suto Y et al Overlapping cardiac volume reduction operation J Thorac Cardiovasc Surg 2002 124 395 397 Nagamatsu H Momose M Kobayashi H et al Prognostic value of 123 metaiodobenzylguanidine in patients with various heart diseases Ann Nucl Med 2007 21 513 520 Har
185. nt Aggarwal A Pant R Kumar S et al Incidence and management of gastrointestinal bleeding with continuous flow assist devices Ann Thorac Surg 2012 93 1534 1540 Kushnir VM Sharma S Ewald GA et al Evaluation of GI bleeding after implantation of left ventricular assist device Gastrointest Endosc 2012 75 973 979 Suarez J Patel CB Felker GM et al Mechanisms of bleeding and approach to patients with axial flow left ventricular assist devices Circ Heart Fail 2011 4 779 784 Stein LH Elefteriades JA Can the occurrence of gastrointestinal bleeding in nonpulsatile left ventricular assist device patients provide clues for the reversal of arteriosclerosis Cardiol Clin 2011 29 641 645 Demirozu ZT Radovancevic R Hochman LF et al Arteriovenous malformation and gastrointestinal bleeding in patients with the HeartMate II left ventricular assist device J Heart Lung Transplant 2011 30 849 853 Hayes HM Dembo LG Larbalestier R et al Management options to treat gastrointestinal bleeding in patients supported on rotary left ventricular assist devices a single center experience Artif Organs 2010 34 703 706 3 Stern DR Kazam J Edwards P et al Increased incidence of gastrointestinal bleeding following implantation of the HeartMate II LVAD J Card Surg 2010 25 352 356 Sandner SE Zimpfer D Zrunek P et al Renal function and outcome after continuous flow left ventricular assist device implantation Ann Thorac Surg 2
186. on of patient self testing competency of prothrombin time for managing anticoagulation pre randomization results of VA Cooperative Study 481 The Home INR Study THINRS J Thromb Thrombolysis 2010 30 263 275 296 Bloomfield HE Krause A Greer N et al Meta analysis effect of patient self testing and self management of long term anticoagulation on major clinical outcomes Ann Intern Med 2011 154 472 482 297 Thoratec Corporation HeartMate I Community Living Manual 2011 105134 B Frequently Asked Questions A2 7 Can I travel 298 Samuels LE Holmes EC Petrucci R Psychosocial and sexual concerns of patients with implantable left ventricular assist devices a pilot study J Thorac Cardiovasc Surg 2004 127 1432 1435 299 Morales DL Argenziano M Oz MC Outpatient left ventricular assist device support a safe and economical therapeutic option for heart failure Prog Cardiovasc Dis 2000 43 55 66 300 Ainsworth BE Haskell WL Herrmann SD et al 2011 Compendium of Physical Activities a second update of codes and MET values Med Sci Sports Exerc 2011 43 1575 1581 301 Thoratec Corporation HeartMate I Community Living Manual 2011 105134 B Frequently Asked Questions A2 6 Will I be able to have sex 302 Cotrufo M De Feo M De Santo LS et al Risk of warfarin during pregnancy with mechanical valve prostheses Obstet Gynecol 2002 99 35 40 303 Lower RR Stofer RC Shumway NE Homovital transplantation of
187. p in patients awaiting heart transplantation Circulation 2012 125 3191 3200 Wieselthaler GM O Driscoll G Jansz P et al HVAD Clinical Investigators Initial clinical experience with a novel left ventricular assist device with a magnetically levitated rotor in a multi institutional trial J Heart Lung Transplant 2010 29 1218 1225 Ushijima T Tanoue Y Hirayama K et al A case of conversion of a NIPRO ventricular assist system to an EVAHEART left ventricular assist system J Artif Organs 2013 16 248 252 Pal JD Klodell CT John R et al Low operative mortality with implantation of a continuous flow left ventricular assist device and impact of concurrent cardiac procedures Circulation 2009 120 8215 219 Mets B Anesthesia for left ventricular assist device placement J Cardiothorac Vasc Anesth 2000 14 316 326 De Simone R Wolf I Mottl Link S et al Intraoperative assessment of right ventricular volume and function Eur J Cardiothorac Surg 2005 27 988 993 Belway D Tee R Nathan HJ et al Temperature management and monitoring practices during adult cardiac surgery under cardiopulmonary bypass results of a Canadian national survey Perfusion 2011 26 395 400 Kertai MD Whitlock EL Avidan MS Brain monitoring with electroencephalography and the electroencephalogram derived bispectral index during cardiac surgery Anesth Analg 2012 114 533 546 Murkin JM Arango M Near infrared spectroscopy as an index of brai
188. re the EVEREST Outcome Trial JAMA 2007 297 1319 1331 Douglas I Hyponatremia why it matters how it presents how we can manage it Cleve Clin J Med 2006 73 S4 12 Leier CV Dei Cas L Metra M Clinical relevance and management of the major electrolyte abnormalities in congestive heart failure hyponatremia hypokalemia and hypomagnesemia Am Heart J 1994 128 564 574 Imamura T Kinugawa K Shiga T et al Correction of hyponatremia by tolvaptan before left ventricular assist device implantation Int Heart J 2012 53 391 393 Mano A Fujita K Uenomachi K et al Body mass index is a useful predictor of prognosis after left ventricular assist system implantation J Heart Lung Transplant 2009 28 428 433 Munoz E Lonquist JL Radovancevic B et al Long term results in diabetic patients undergoing heart transplantation J Heart Lung Transplant 1992 11 943 949 Carr JG Stevenson LW Walden JA et al Prevalence and hemodynamic correlates of malnutrition in severe congestive heart failure secondary to ischemic or idiopathic dilated cardiomyopathy Am J Cardiol 1989 63 709 713 Schwengel RH Gottlieb SS Fisher ML Protein energy malnutrition in patients with ischemic and nonischemic dilated cardiomyopathy and congestive heart failure Am J Cardiol 1994 73 908 910 Dickstein K Vardas PE Auricchio A et al 2010 Focused Update of ESC Guidelines on device therapy in heart failure an update of the 2008 ESC Guidelines for th
189. ris KM Spirito P Maron MS et al Prevalence clinical profile and significance of left ventricular remodeling in the end stage phase of hypertrophic cardiomyopathy Circulation 2006 114 216 225 Biagini E Coccolo F Ferlito M et al Dilated hypokinetic evolution of hypertrophic cardiomyopathy prevalence incidence risk factors and prognostic implications in pediatric and adult patients J Am Coll Cardiol 2005 46 1543 1550 Thaman R Gimeno JR Murphy RT et al Prevalence and clinical significance of systolic impairment in hypertrophic cardiomyopathy Heart 2005 91 920 925 Matsumori A Furukawa Y Hasegawa K et al Epidemiologic and clinical characteristics of cardiomyopathies in Japan results from nationwide surveys Circ J 2002 66 323 336 Ha JW Ommen SR Tajik AJ et al Differentiation of constrictive pericarditis from restrictive cardiomyopathy using mitral annular velocity by tissue Doppler echocardiography Am J Cardiol 2004 94 316 319 Marcus FI McKenna WJ Sherrill D et al Diagnosis of arrhythmogenic right ventricular cardiomyopathy dysplasia proposed modification of the task force criteria Circulation 2010 121 1533 1541 2006 54 955 961 Kandolin R Lehtonen J Graner M et al Diagnosing isolated cardiac sarcoidosis J Intern Med 2011 270 461 468 Milman N
190. ssist device to a biventricular assist device J Thorac Cardiovasc Surg 2009 137 971 977 Matthews JC Koelling TM Pagani FD et al The right ventricular failure risk score a pre operative tool for assessing the risk of right ventricular failure in left ventricular assist device candidates J Am Coll Cardiol 2008 51 2163 2172 Kormos RL Teuteberg JJ Pagani FD et al HeartMate II Clinical Investigators Right ventricular failure in patients with the HeartMate II continuous flow left ventricular assist device incidence risk factors and effect on outcomes J Thorac Cardiovasc Surg 2010 139 1316 1324 Shiga T Kinugawa K Imamura T et al Combination evaluation of preoperative risk indices predicts requirement of biventricular assist device Circ J 2012 76 2785 2791 Saito S Sakaguchi T Sawa Y Clinical report of long term support with dual Jarvik 2000 biventricular assist device J Heart Lung Transplant 2011 30 845 847 Krabatsch T Potapov E Stepanenko A et al Biventricular circulatory support with two miniaturized implantable assist devices Circulation 2011 124 8179 186 Saito S Sakaguchi T Miyagawa S et al Biventricular support using implantable continuous flow ventricular assist devices J Heart Lung Transplant 2011 30 475 478 Catena E Milazzo F Montorsi E et al Left ventricular support by axial flow pump the echocardiographic approach to device malfunction J Am Soc Echocardiogr 2005 18 1422 Jaski B
191. t with attenuated pulse pressure alters human aortic wall morphology J Thorac Cardiovasc Surg 2007 133 575 576 Grohmann J Blanke P Benk C et al Trans catheter closure of the native aortic valve with an Amplatzer Occluder to treat progressive aortic regurgitation after implantation of a left ventricular assist device Eur J Cardiothorac Surg 2011 39 e181 183 Fujita T Kobayashi J Hata H et al Aortic valve closure for rapidly deteriorated aortic insufficiency after continuous flow left ventricular assist device implantation J Artif Organs 2013 16 98 100 D Ancona G Pasic M Buz S et al TAVI for pure aortic valve insufficiency in a patient with a left ventricular assist device Ann Thorac Surg 2012 93 e89 91 Kashiwa K Nishimura T Kubo H et al Study of device malfunctions in patients with implantable ventricular assist devices living at home J Artif Organs 2010 13 134 138 Dowling RD Park SJ Pagani FD et al HeartMate VE LVAS design enhancements and its impact on device reliability Eur J Cardiothorac Surg 2004 25 958 963 Birks EJ Tansley PD Yacoub MH et al Incidence and clinical management of life threatening left ventricular assist device failure J Heart Lung Transplant 2004 23 964 969 Gregoric ID Exchange techniques for implantable ventricular assist devices ASAIO J 2008 54 14 19 Adamson RM Dembitsky WP Baradarian S et al HeartMate left ventricular assist system exchange results and technical
192. ter study of the LVAD Working Group Circulation 2007 115 2497 2505 Dandel M Weng Y Siniawski H et al Long term results in patients with idiopathic dilated cardiomyopathy after weaning from left ventricular assist devices Circulation 2005 112 137 45 Matsumiya G Saitoh S Sakata Y et al Myocardial recovery by mechanical unloading with left ventricular assist system Circ J 2009 73 1386 1392 Goldstein DJ Maybaum S MacGillivray TE et al Young patients with nonischemic cardiomyopathy have higher likelihood of left ventricular recovery during left ventricular assist device support J Card Fail 2012 18 392 395 Krabatsch T Schweiger M Dandel M et al Is bridge to recovery more likely with pulsatile left ventricular assist devices than with nonpulsatile flow systems Ann Thorac Surg 2011 91 1335 1340 Cohn WE Gregoric ID Radovancevic B et al A felt plug simplifies left ventricular assist device removal after successful bridge to recovery J Heart Lung Transplant 2007 26 1209 1211 Brush S Budge D Alharethi R et al End of life decision making and implementation in recipients of a destination left ventricular assist device J Heart Lung Transplant 2010 29 1337 1341 AY 5 2011 81 128 2012 10 H
193. ton SC Khodaverdian R Chatelain P et al Left ventricular assist device malfunction an approach to diagnosis by echocardiography J Am Coll Cardiol 2005 45 1435 1440 Wellford AL Lawrie G Zoghbi WA Transesophageal echocardiographic features and management of retained intracardiac air in two patients after surgery J Am Soc Echocardiogr 1996 9 182 186 3 Utley JR Techniques for avoiding neurologic injury during adult cardiac surgery J Cardiothorac Vasc Anesth 1996 10 38 43 quiz 43 34 Farrar DJ Compton PG Hershon JJ et al Right heart interaction with the mechanically assisted left heart World J Surg 1985 9 89 102 Dembitsky W Naka Y Chapter 12 Intraoperative management 166 167 168 169 170 17 172 174 175 176 177 178 179 180 181 182 183 184 185 186 issues in mechanical circulatory support In Kormos RL Miller LW editors Mechanical circulatory support a companion to Braunwald s heart disease Elsevier Saunders 2012 153 165 Loebe M Potapov E Sodian R et al A safe and simple method of preserving right ventricular function during implantation of a left ventricular assist device J Thorac Cardiovasc Surg 2001 122 1043 Van Meter CH Robbins RJ Ochsner JL Technique of right heart protection and deairing during heartmate vented electric LVAD implantation Ann Thorac Surg 1997 63 1191 1192 Dewey TM Chen JM Spanier TB
194. tricular assist device for circulatory support during high risk percutaneous coronary intervention Int J Cardiovasc Intervent 2003 5 35 39 Meyns B Dens J Sergeant P et al Initial experiences with the Impella device in patients with cardiogenic shock Impella support for cardiogenic shock Thorac Cardiovasc Surg 2003 51 312 317 Cheng JM den Uil CA Hoeks SE et al Percutaneous left ventricular assist devices vs intra aortic balloon pump counterpulsation for treatment of cardiogenic shock a meta analysis of controlled trials Eur Heart J 2009 30 2102 2108 http www uab edu intermacs i http www info _pmda go jp kyoten_kiki track html http www jacvas com cee REECE LZ 2012 4 11 12 EE 2012 4 0404002 2008 4 4 ATA 2007 2007 5 Altieri F Berson A Borovetz H et al Long term mechanical circulatory support system reliability recommendation American Society for Artificial Internal Organs and Society of Thoracic Surgeons long term mechanical circulatory support system reliability recommendation
195. unt SA Abraham WT Chin MH et al 2009 focused update incorporated into the ACC AHA 2005 Guidelines for the Diagnosis and Management of Heart Failure in Adults a report of the American College of Cardiology Foundation American Heart Association Task Force on Practice Guidelines developed in collaboration with the International Society for Heart and Lung Transplantation Circulation 2009 119 e391 479 Heart Failure Society of America Lindenfeld J Albert NM et al HFSA 2010 Comprehensive Heart Failure Practice Guideline J Card Fail 2010 16 e1 194 Arnold JM Liu P Demers C et al Canadian Cardiovascular Society Canadian Cardiovascular Society consensus conference recommendations on heart failure 2006 diagnosis and management Can J Cardiol 2006 22 23 45 Peura JL Colvin Adams M Francis GS et al Recommendations for the use of mechanical circulatory support device strategies and patient selection a scientific statement from the American Heart Association Circulation 2012 126 2648 2667
Download Pdf Manuals
Related Search